ArticlePediatric nephrology (Berlin, Germany)2019

Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way.

Gema AricetaPubMed ↗Publisher ↗

No numbers read from the abstract.